First introduced as a treatment for Type 2 diabetes and now pursued as a blockbuster weight management therapy, GLP-1 receptor agonists (GLP-1 RAs) have ignited a global scale-up effort that is reshaping the drug manufacturing landscape
We supply to about 2000 patients a month indirectly or directly and have been seen MoM growth which is decent , however there was a lot of frontloading of stocks by generic players and that correction is happening.
Clinical trials have shown that retatrutide can produce weight loss results in as little as 4 weeks
Common side effects include nausea, diarrhea, vomiting, constipation, stomach discomfort, rash or pain around the injection site, fatigue, burping, hair loss, and gastroesophageal reflux disease
L.ShenH.LiuL.WangL.LiB.FangP.et al
12 mg per week The maximum dose studied, associated with the most pronounced reductions in body weight, with some participants experiencing losses exceeding 24% over a 48-week period
